Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2000; 36:1142-1151
© 2000 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cantor, W. J.
Right arrow Articles by Ohman, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cantor, W. J.
Right arrow Articles by Ohman, E. M.

REVIEW ARTICLE

Provisional stenting strategies: systematic overview and implications for clinical decision-making

Warren J. Cantor, MD*, Eric D. Peterson, MD, MPH, FACC*, Jeffrey J. Popma, MD, FACC{dagger}, James P. Zidar, MD, FACC*, Michael H. Sketch, Jr., MD, FACC*, James E. Tcheng, MD, FACC* and E. Magnus Ohman, MD, FACC*

* Duke Clinical Research Institute, Durham, North Carolina, USA
{dagger} Brigham and Women’s Hospital, Boston, Massachusetts, USA

Manuscript received August 9, 1999; revised manuscript received March 23, 2000, accepted May 24, 2000.

Reprint requests and correspondence: Dr. Warren J. Cantor, Division of Cardiology, St. Michael’s Hospital, 30 Bond Street, Toronto, Ontario, Canada MSB 1WB
canto001{at}mc.duke.edu

Coronary stents reduce the rates of abrupt closure, emergency coronary artery bypass graft surgery and restenosis, but do not prevent myocardial infarction or death at six months. The financial burden of increased stent use and the difficulty in managing in-stent restenosis have provided the impetus to develop provisional stenting strategies. Patients at low risk for restenosis after balloon angioplasty may not derive additional benefit from stent implantation and may be successfully managed with percutaneous transluminal coronary angioplasty (PTCA) alone. Numerous patient, lesion and procedural predictors of restenosis have been identified. Postprocedural assessment using quantitative coronary angiography, intravascular ultrasound (IVUS), coronary flow velocity reserve (CVR) or fractional flow reserve (FFR) may further enhance the ability to predict adverse outcomes after PTCA. Several studies have been performed to investigate the feasibility of provisional stenting strategies using various modalities to identify low risk patients who could be managed with PTCA alone. An optimal or "stent-like" angiographic result after PTCA is associated with favorable clinical outcomes. Preliminary results of studies using IVUS or CVR to guide provisional stenting appear promising. Angiography alone may be inadequate to identify truly low risk patients and may need to be combined with clinical factors, assessment of recoil, IVUS or physiologic indexes. Strategies that avoid unnecessary stenting in even a small proportion of patients may have large impacts on health care costs. Provisional stenting may potentially reduce costs and rates of in-stent restenosis without compromising the quality of health care delivery.

Abbreviations and Acronyms
  CVR = coronary flow velocity reserve
  FFR = fractional flow reserve
  IVUS = intravascular ultrasound
  LAD = left anterior descending coronary artery
  MI = myocardial infarction
  MLD = minimum lumen diameter
  PTCA = percutaneous transluminal coronary angioplasty
  QCA = quantitative coronary angiography
  TLR = target lesion revascularization




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. A. Cox, G. W. Stone, C. L. Grines, T. Stuckey, D. J. Cohen, J. E. Tcheng, E. Garcia, G. Guagliumi, R. S. Iwaoka, M. Fahy, et al.
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 971 - 977.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Brophy, P. Belisle, and L. Joseph
Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis
Ann Intern Med, May 20, 2003; 138(10): 777 - 786.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Schiele, N. Meneveau, M. Gilard, J. Boschat, P. Commeau, L. P. Ming, P. Sewoke, M.-F. Seronde, M. Mercier, S. Gupta, et al.
Intravascular Ultrasound-Guided Balloon Angioplasty Compared With Stent: Immediate and 6-Month Results of the Multicenter, Randomized Balloon Equivalent to Stent Study (BEST)
Circulation, February 4, 2003; 107(4): 545 - 551.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
D. C. Lee, W. Ting, and M. C. Oz
Myocardial Revascularization after Acute Myocardial Infarction
Card. Surg. Adult, January 1, 2003; 2(2003): 639 - 658.
[Full Text]


Home page
Eur Heart JHome page
J.J Piek, E Boersma, M Voskuil, C di Mario, E Schroeder, C Vrints, P Probst, B de Bruyne, C Hanet, E Fleck, et al.
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study
Eur. Heart J., September 2, 2001; 22(18): 1725 - 1732.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement